Correction (DOI:10.1016/j.jacc.2008.10.061);Renal Protective Effects and the Prevention of Contrast-Induced Nephropathy by Atrial Natriuretic Peptide

Journal of the American College of Cardiology

Volumn 53, Issue 12, 2009, Pages 1040-1046

  Morikawa, Shuji ^a   Sone, Takahito ^a   Tsuboi, Hideyuki ^a   Mukawa, Hiroaki ^a   Morishima, Itsuro ^a   Uesugi, Michitaka ^a   Morita, Yasuhiro ^a,b   Numaguchi, Yasushi ^c   Okumura, Kenji ^c   Murohara, Toyoaki ^b  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

atrial natriuretic peptide; contrast induced nephropathy; coronary angiography; creatinine; eGFR

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR ALPHA; CALCIUM CHANNEL BLOCKING AGENT; CONTRAST MEDIUM; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RINGER SOLUTION;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTRAST INDUCED NEPHROPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; HUMAN; HYDRATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION;

EID: 61949457295     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.08.004     Document Type: Erratum

References (33)

1. McCullough P.A., Wolyn R., Rocher L.L., Levin R.N., and O'Neill W.W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103 (1997) 368-375
2. Tepel M., Aspelin P., and Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation 113 (2006) 1799-1806
3. Gruberg L., Mintz G.S., Mehran R., et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36 (2000) 1542-1548
4. Levy E.M., Viscoli C.M., and Horwitz R.I. The effect of acute renal failure on mortality. A cohort analysis. JAMA 275 (1996) 1489-1494
5. Solomon R., and Deray G. How to prevent contrast-induced nephropathy and manage risk patients: practical recommendations. Kidney Int 69 Suppl S100 (2006) S51-S53
6. Goetz K.L. Physiology and pathophysiology of atrial peptides. Am J Physiol 254 (1988) E1-E15
7. Nakamoto M., Shapiro J.I., Shanley P.F., Chan L., and Schrier R.W. In vitro and in vivo protective effect of atriopeptin III on ischemic acute renal failure. J Clin Invest 80 (1987) 698-705
8. Conger J.D., Falk S.A., Yuan B.H., and Schrier R.W. Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure. Kidney Int 35 (1989) 1126-1132
9. Rahman S.N., Kim G.E., Mathew A.S., et al. Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int 45 (1994) 1731-1738
10. Valsson F., Ricksten S.E., Hedner T., Zall S., William-Olsson E.B., and Lundin S. Effects of atrial natriuretic peptide on renal function after cardiac surgery and in cyclosporine-treated heart transplant recipients. J Cardiothorac Vasc Anesth 8 (1994) 425-430
11. Valsson F., Ricksten S.E., Hedner T., and Lundin S. Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery. Intensive Care Med 22 (1996) 230-236
12. Kurnik B.R., Weisberg L.S., Cuttler I.M., and Kurnik P.B. Effects of atrial natriuretic peptide versus mannitol on renal blood flow during radiocontrast infusion in chronic renal failure. J Lab Clin Med 116 (1990) 27-36
13. Weisberg L.S., Kurnik P.B., and Kurnik B.R. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 45 (1994) 259-265
14. Kurnik B.R., Allgren R.L., Genter F.C., Solomon R.J., Bates E.R., and Weisberg L.S. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 31 (1998) 674-680
15. Merten G.J., Burgess W.P., Gray L.V., et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291 (2004) 2328-2334
16. Imai E., Horio M., Nitta K., et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 11 (2007) 41-50
17. Maeder M., Klein M., Fehr T., and Rickli H. Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol 44 (2004) 1763-1771
18. McCullough P.A. Contrast-induced acute kidney injury. J Am Coll Cardiol 51 (2008) 1419-1428
19. Romano G., Briguori C., Quintavalle C., et al. Contrast agents and renal cell apoptosis. Eur Heart J 29 (2008) 2569-2576
20. Lanese D.M., Yuan B.H., Falk S.A., and Conger J.D. Effects of atriopeptin III on isolated rat afferent and efferent arterioles. Am J Physiol 261 (1991) F1102-F1109
21. Roy D.R. Effect of synthetic ANP on renal and loop of Henle functions in the young rat. Am J Physiol 251 (1986) F220-F225
22. Davis C.L., and Briggs J.P. Effect of atrial natriuretic peptides on renal medullary solute gradients. Am J Physiol 253 (1987) F679-F684
23. Meyer-Lehnert H., Bayer T., Predel H.G., Glanzer K., and Kramer H.J. Effects of atrial natriuretic peptide on systemic and renal hemodynamics and renal excretory function in patients with chronic renal failure. Klin Wochenschr 69 (1991) 895-903
24. Sandok E.K., Lerman A., Stingo A.J., Perrella M.A., Gloviczki P., and Burnett Jr. J.C. Endothelin in a model of acute ischemic renal dysfunction: modulating action of atrial natriuretic factor. J Am Soc Nephrol 3 (1992) 196-202
25. Allgren R.L., Marbury T.C., Rahman S.N., et al., Auriculin Anaritide Acute Renal Failure Study Group. Anaritide in acute tubular necrosis. N Engl J Med 336 (1997) 828-834
26. Conger J.D., Schultz M.F., Miller F., and Robinette J.B. Responses to hemorrhagic arterial pressure reduction in different ischemic renal failure models. Kidney Int 46 (1994) 318-323
27. Sward K., Valsson F., Odencrants P., Samuelsson O., and Ricksten S.E. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med 32 (2004) 1310-1315
28. Andrew E., and Berg K.J. Nephrotoxic effects of X-ray contrast media. J Toxicol Clin Toxicol 42 (2004) 325-332
29. Katzberg R.W. Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity. Radiology 204 (1997) 297-312
30. Newman D.J., Thakkar H., Edwards R.G., et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 47 (1995) 312-318
31. Artunc F.H., Fischer I.U., Risler T., and Erley C.M. Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization. Int J Cardiol 102 (2005) 173-178
32. Lassnigg A., Schmidlin D., Mouhieddine M., et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 15 (2004) 1597-1605
33. Weisbord S.D., Chen H., Stone R.A., et al. Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. J Am Soc Nephrol 17 (2006) 2871-2877